Catheters, catheter-based systems, and methods thereof for treating hypervolemia
A catheter ( 100 ) for treating hypervolemia in a patient includes a luminal ingress ( 112 ) joined to a luminal egress ( 114 ) at a distal end portion ( 116 ) of the catheter having a closed distal end ( 102 ). The distal end portion is configured to at least temporarily reside within a vessel of the patient, the distal end portion including a semipermeable membrane. The luminal ingress is designed to convey an influent having a first osmotic concentration to the distal end portion. The semipermeable membrane is configured to pass blood-borne water from the vessel into the distal portion. The blood-borne water is absorbed by the influent to produce an effluent having a second osmotic concentration lower than the first osmotic concentration. Systems ( 200 ) with the catheter and methods for treating hypervolemia are also disclosed.
1. A catheter for treating hypervolemia in a patient, comprising:
a distal end portion having a closed distal end configured to at least temporarily reside within a vessel of the patient;
a luminal ingress joined to a luminal egress at the distal end portion, the luminal ingress designed to convey an influent having a first osmotic concentration to the distal end portion, wherein an abluminal surface of the luminal ingress is configured to be in direct contact with a fluid within the vessel of the patient; and
a semipermeable membrane configured to pass blood-borne water from the vessel into at least the distal end portion, the blood-borne water absorbed by the influent to produce an effluent having a second osmotic concentration lower than the first osmotic concentration.
2. The catheter according to claim 1 , wherein the catheter is a single-lumen catheter, the single-lumen catheter folded at a fold proximal of the closed end of the catheter.
3. The catheter according to claim 1 , further comprising a septum disposed between the luminal ingress and the luminal egress, wherein a distal end of the septum is proximal of the closed distal end of the catheter.
4. The catheter according to claim 1 , wherein the semipermeable membrane has a pore size configured to allow the blood-borne water in the vessel of the patient to permeate through the semipermeable membrane but not larger blood-borne metabolites including polypeptides or proteins, cell fragments, or cells.
5. The catheter according to claim 1 , wherein the abluminal surface of the catheter includes a surface area-increasing means to increase a surface area of the abluminal surface over that without the surface area-increasing means, thereby increasing a flux of the blood-borne water from the vessel of the patient through the semipermeable membrane.
6. The catheter according to claim 1 , wherein the influent is an aqueous solution including a dissolved polymer, and wherein the first osmotic concentration is sufficient to create an osmotic potential for removing blood-borne the water from the vessel in excess of that the patient needs through the semipermeable membrane.
7. A system for treating hypervolemia, comprising:
a) a catheter including:
a distal end portion having a closed distal end configured to at least temporarily reside within a vessel of a patient;
a luminal ingress joined to a luminal egress at the distal end portion, the luminal ingress designed to convey an influent having a first osmotic concentration to the distal end portion, wherein an abluminal surface of the luminal ingress is configured to be in direct contact with a fluid within the vessel of the patient; and
a semipermeable membrane configured to pass blood-borne water from the vessel into at least the distal end portion, the blood-borne water absorbed by the influent to produce an effluent having a second osmotic concentration lower than the first osmotic concentration; and
b) a fluid-collection system including:
a reservoir configured to collect the effluent; and
a pump configured to move one or more fluids of the system including the influent and the effluent.
8. The system according to claim 7 , the fluid-collection system further comprising an ultrafiltration membrane configured to produce a membrane permeate consisting essentially of the blood-borne water from the vessel of the patient and a membrane retentate for the influent.
9. The system according to claim 8 , the fluid-collection system further comprising a shunt configured to shunt the membrane permeate to a bladder of the patient for elimination.
10. The system according to claim 8 , the fluid-collection system further comprising a switch valve configured to switch a mode of the fluid-collection system from collecting the blood-borne water from the vessel of the patient in the reservoir to producing the membrane permeate and the membrane retentate for the influent.
11. The system according to claim 7 , the catheter further comprising a septum disposed between the luminal ingress and the luminal egress, wherein a distal end of the septum is proximal of the closed distal end of the catheter.
12. The system according to claim 7 , wherein the semipermeable membrane has a pore size configured to allow the blood-borne water in the vessel of the patient to permeate through the semipermeable membrane but not larger blood-borne metabolites including polypeptides or proteins, cell fragments, or cells.
13. The system according to claim 7 , wherein the influent is an aqueous solution including a dissolved polymer, and wherein the first osmotic concentration is sufficient to create an osmotic potential for removing the blood-borne water from the vessel in excess of that the patient needs through the semipermeable membrane.
14. A method for treating hypervolemia, comprising:
inserting a closed-ended catheter in a vessel of a patient, the close-ended catheter comprising:
a distal end portion;
a luminal ingress joined to a luminal egress at the distal end portion; and
a semipermeable membrane;
directing an influent into the luminal ingress having a first osmotic concentration;
absorbing blood-borne water from the vessel into at least the distal end portion through the semipermeable membrane to produce an effluent having a second osmotic concentration lower than the first osmotic concentration; and
directing the effluent out of the closed-ended catheter by way of the luminal egress.
15. The method according to claim 14 , further comprising: pumping the influent into the luminal ingress and pumping the effluent out of the luminal egress with a pump fluidly coupled to the closed-ended catheter.
16. The method according to claim 14 , further comprising: disposing the effluent as a waste product.
17. The method according to claim 14 , further comprising: recycling the effluent with a fluid-collection system to produce the influent.
18. The method according to claim 17 , wherein directing the effluent out of the closed-ended catheter includes directing the effluent into a fluid reservoir of the fluid-collection system.
19. The method according to claim 18 , further comprising: switching a mode of the fluid-collection system from collecting the effluent with the fluid reservoir to filtering the effluent with an ultrafiltration membrane of the fluid-collection system, wherein filtering the effluent produces a water-based membrane permeate and a membrane retentate of the influent.
20. The method according to claim 19 , further comprising: shunting the water-based membrane permeate to a bladder of the patient for elimination.
21. The catheter according to claim 1 , wherein the semipermeable membrane is disposed at the distal end portion.
22. The system according to claim 7 , wherein the semipermeable membrane is disposed at the distal end portion.
23. The method according to claim 14 , wherein the semipermeable membrane is disposed at the distal end portion.